Drosophila mutants lacking the glial neurotransmitter-modifying enzyme Ebony exhibit low neurotransmitter levels and altered behavior

Inhibitors of enzymes that inactivate amine neurotransmitters (dopamine, serotonin), such as catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), are thought to increase neurotransmitter levels and are widely used to treat Parkinson's disease and psychiatric disorders, yet the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantalia, Meghan, Lin, Zhi, Tener, Samantha J., Qiao, Bing, Tang, Grace, Ulgherait, Matthew, O’Connor, Reed, Delventhal, Rebecca, Volpi, Julia, Syed, Sheyum, Itzhak, Nissim, Canman, Julie C., Fernández, María Paz, Shirasu-Hiza, Mimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300103/
https://www.ncbi.nlm.nih.gov/pubmed/37369755
http://dx.doi.org/10.1038/s41598-023-36558-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300103/
https://www.ncbi.nlm.nih.gov/pubmed/37369755
http://dx.doi.org/10.1038/s41598-023-36558-7

Ejemplares similares